<DOC>
	<DOCNO>NCT02503566</DOCNO>
	<brief_summary>Cardiac allograft vasculopathy ( CAV ) characterize mark intimal proliferation concentric vascular thicken fibrosis . CAV remain leading cause late morbidity mortality heart transplant recipient . Optical coherence tomography ( OCT ) new generation catheter-based modality acquire image spatial resolution 10-20 μm 10-fold great intravascular ultrasound ( IVUS ) . OCT currently sensitive image technique early CAV detection . Recent study prove circulate human leukocyte antigen ( HLA ) direct donor-specific antibody correlate increase mortality CAV . Contradiction scientific result report regard increase rest heart rate development CAV . Larger prospective study use sensitive CAV detect method require enhance understanding . Novel immunosuppressant , mechanistic target rapamycin ( mTOR ) inhibitor , may attenuate CAV progression may improve long-term allograft survival owe favorable coronary remodeling . Aim study : Use OCT image identification patient early rapid progression CAV ( rapid progressors ) identify critical risk factor responsible CAV progression . The impact conventional heart transplant ( HTx ) specific risk factor , donor-specific antibody rapid heart rate study prospective , national-level cohort study . The implication OCT result lead adjustment immunosuppressive therapy one year heart transplant prevent progression disease CAV rapid progressors . Working hypothesis : 1 . Patients rapid progression cardiac allograft vasculopathy identify increased titer donor specific anti-human leukocyte antigen ( anti-HLA ) and/or antibody major histocompatibility complex ( MHC ) class I-related chain A ( MICA ) antibody . 2 . Specific high-risk characteristic anti-HLA antibody identify associate particularly high rate CAV progression ( vascular complement activation biopsy , certain HLA haplotype ) . 3 . Tachycardia heart transplant recipient represent risk factor development cardiac allograft vasculopathy . 4 . Influence anti-HLA antibody increase heart rate independent already establish risk factor CAV .</brief_summary>
	<brief_title>Assessment Cardiac Allograft Vasculopathy Optical Coherence Tomography</brief_title>
	<detailed_description>Cardiac allograft vasculopathy ( CAV ) represent leading cause late morbidity mortality heart transplant recipient account second all-cause mortality 3 year . Development CAV complex process involve intimal thickening , atherosclerosis , thrombosis vasculitis histology , ultimately , intimal hyperplasia predominant cause lumen narrow , lead ischemia graft failure . In distinction general coronary atherosclerosis , mark focal eccentric fibrofatty atheroma , CAV affect diffusely entire coronary vasculature mark intimal proliferation concentric vascular thicken fibrosis . Optical coherence tomography ( OCT ) , compare IVUS , sensitive early detection CAV . OCT new generation catheter-based modality acquire image spatial resolution 10-20 μm 10-fold great IVUS . OCT could obviously identify layer medium lower-echoic line , could identify IVUS . When assess quality intracoronary structure accurately , OCT seem potential IVUS . The endothelial cell cardiac vasculature express human leukocyte antigen ( HLA ) others , vimentin major histocompatibility complex ( MHC ) class I-related chain A ( MICA ) , appear primary target cell-mediated humoral immune response heart transplant ( HTx ) . Circulating antibody mediate rejection complement activation fixation graft endothelium , thereby predispose patient graft loss , accelerate cardiac allograft vasculopathy , death . The rate allosensitized patient ( patient circulate antibody donor antigen ) wait list increase consequence grow number retransplants assist-device implantation . Allosensitization consequence exposure disparate HLA molecules pregnancy , blood/platelet transfusion , cardiac repair homograft material , may occur patient even without trigger unknown reason . Orthotopic heart transplantation accompany sympathetic parasympathetic denervation . The subsequent heart rate usually high circadian variation low due elimination vagus nerve effect . It known persistent increase heart rate contributes pathogenesis vascular disease . AIMS OF THE PROJECT The aim study use OCT image identification patient early rapid progression cardiac allograft vasculopathy ( rapid progressors ) identify critical risk factor responsible CAV progression . The impact conventional HTx-specific risk factor , donor-specific antibody ( use sensitive method measurement ) rapid heart rate ( use repeat Holter monitoring ) study prospective , national-level cohort study . The implication OCT result lead adjustment immunosuppressive therapy one year heart transplant prevent progression disease CAV rapid progressors . WORKING HYPOTHESES 1 . Patients rapid progression cardiac allograft vasculopathy identify increased titer donor specific anti-HLA and/or MICA antibody . 2 . Specific high-risk characteristic anti-HLA antibody identify associate particularly high rate CAV progression ( vascular complement activation biopsy , certain HLA haplotype ) . 3 . Tachycardia heart transplant recipient represent risk factor development cardiac allograft vasculopathy . 4 . Influence anti-HLA antibody increase heart rate independent already establish risk factor CAV . STUDY DESIGN Collection data blood sample perform time patient 's regularly schedule surveillance cardiac catheterization ( 1 month 12 month heart transplant ) . Additionally donor-specific anti-HLA antibody ( class I , II ) MHC complex class I - relate chain A ( MICA ) antibody measure also heart transplant 6 month heart transplant regular follow-up . OCT ( optical coherency tomography ) image performed time patient 's regularly schedule surveillance cardiac catheterization ( 1 month 12 month heart transplant ) . OCT image perform commercially available second-generation frequency domain Ilumien Optis ( St. Jude Medical , St. Paul , MN ) . The OCT catheter ( Dragonfly Duo ) advance 0.014-inch coronary guide wire middle segment three main artery ( leave anterior descend , leave circumflex right coronary artery ) imaging perform automated pullback length 45 mm , pullback speed 25 mm/sec high resolution mode ( 10 frame /mm ) . OCT examination perform administration 200-300 μg intracoronary nitroglycerin simultaneous injection 14 ml contrast agent artery power injector guide catheter . OCT data use 3-D vessel reconstruction do fusion routine angiography perform two projection least 60 degree apart . The image data acquire two-plane angiography , utilized accurately reconstruct path orientation OCT catheter 3-D . The two-plane angiogram take immediately prior pullback start cover least one heart cycle . They use extract catheter path automatically along expect pullback trajectory dynamic programming approach . From know image geometry , accurate 3-D model catheter path within respective vessel segment generate end-diastolic heart phase . For OCT acquisition , motorize pullback ensure constant pullback speed , thus allow assign OCT image frame specific location 3-D catheter trajectory model . The relative absolute orientation OCT frame determine use previously report system establish absolute orientation 3-D IVUS image . Quantitative data derive contour data , luminal dimension plaque-cap thickness , actually consider vessel curvature contrast conventional OCT reconstruction system . The space adjacent contour interpolate form volume element . In location plaque cap , integrate entire vessel segment part thereof yield total plaque cap volume enclose inner out cap surface . The OCT examination analyze accord OCT consensus standard definition . Intima recognize uniform signal-rich bright layer medium signal-poor darker layer due low backscatter . The lumen , intima , medium layer trace automatically manual correction obtain average thickness area every frame . The segment without sign coronary atherosclerosis coronary angiography use OCT examination . Following index analyze : 1 . Normalized intimal volume : sum intimal cross sectional area ( difference medium area lumen area ) every frame / pullback length . 2 . Normalized lumen volume : sum lumen cross sectional area every frame / pullback length . 3 . Mean intima thickness : value sufficient quality frame average yield average intima thickness . 4 . Mean intima-to-media ratio ( I/M ) : Values sufficient quality frame average yield average intima thickness , medium thickness . The intima-to-media ratio ( I/M ) calculate ratio average area layer whole pullback . An I/M ratio 1 define abnormal . These index compare baseline follow-up examination . After identification vascular landmark correspond two 3-D vessel model , patient specific model pairs co-registered correctly match OCT pullback . OCT baseline follow-up examination perform Prague ( IKEM hospital ) Brno ( Saint Anna hospital ) data send core lab Iowa Institute Biomedical Imaging , The University Iowa , USA analysis . Iowa Institute Biomedical Imaging research centre , extensive experience evaluation coronary atherosclerosis . For purpose detailed analysis coronary artery unique software create 3-D reconstruction coronary artery base fusion angiography optical coherence tomography develop institution . This software enable exact assessment plaque lumen volume . Software protect U.S. patent . Because large volume data patient project , application automate analytic tool prerequisite successful accomplishment . Mean heart rate measure 24 hour ECG Holter monitoring , evaluate necessary parameter include circadian variability . ECG Holter recording perform 1 month 12 month heart transplant . In addition mean 24 hour heart rate , time frequency domain component heart rate variability analyze obtain estimate extent vagal reinnervation . Donor-specific anti-HLA antibody ( class I , II ) MHC complex class I - relate chain A ( MICA ) antibody measure ( heart transplant , 1 month , 6 month 12 month heart transplant ) . Evaluation anti-HLA antibody level ( titer ) serum patient perform fluorescence intensity form complex . Double laser cytometer Luminex 100 IS 2.3 use fluorescence read . Based comparison negative positive control , cut-off calculate . Conventional risk factor CAV determine 1 month 12 month heart transplant . Lipid profile ( total cholesterol , LDL , HDL triglycerides ) measure . Blood pressure triplicate measure supine position ( 1 hour regular endomyocardial biopsy ) . Glycemic control quantify measurement Hemoglobin A1 level , plasma glucose . Cytomegalovirus ( CMV ) status measure immunoglobulin G ( IgG ) , immunoglobulin M ( IgM ) titer . Other monitor parameter : 1 ) post transplant course clinical status ; occurrence graft dysfunction ( echocardiographic monitoring follow endomyocardial biopsy ) , 2 ) occurrence cellular and/or humoral rejection endomyocardial biopsy ( 8 protocolar endomyocardial biopsy within 12 month heart transplantation ) , 3 ) presence tissue distribution ( vascular/non-vascular ) stain complement fragment C3 C4 ( marker antibodies-mediated complement activation ) , 4 ) period cardiac allograft cold ischemia 5 ) aetiology brain death donor 6 ) degree HLA mismatch donor recipient , 7 ) blood cytokine level involve regulation humoral immune response .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>All new cardiac transplant recipient ≥18 year Severe renal dysfunction ( GFR le 30 ml/min ) Active infection Active cellular/humoral rejection Unwilling unable sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>CAV</keyword>
	<keyword>OCT</keyword>
	<keyword>heart rate</keyword>
	<keyword>antibody</keyword>
</DOC>